The Florida Health Department has closed all state-run monoclonal antibody treatment sites after the FDA revoked the infusion drugs saying they don’t work against the Omicron variant which is now dominating the nation.
Governor DeSantis calls the decision “sudden, reckless and not based on any data.”
The Food and Drug Administration Monday announced revoking emergency authorization use for both Regeneron and Eli Lilly.
If the drugs prove effective against future variants, the FDA said it could reauthorize their use.
Meanwhile, Dr. Fauci says the country may be able to return to a sense of normalcy soon barring any new variants.

Also pediatric cases of Omicron are dropping.
Pfizer and its German partner BioNTech have also just announced they’ve begun clinical trials using an Omicron specific COVID vaccine.

Meanwhile, COVID-19 patients can still get monoclonal treatment in the hospital using the drug sotrovimab, from GlaxoSmithKline.
The FDA says sotrovimab is “expected to work against the omicron variant” and is authorized “to treat patients with mild-to-moderate COVID-19 who are at high risk of severe disease, including hospitalization or death.